Current advances of pharmacological properties of 7-chloro-4-(phenylselanyl) quinoline: Prevention of cognitive deficit and anxiety in Alzheimer's disease model.

Abstract

This study investigated the effect of 7-chloro-4-(phenylselanyl) quinoline (4-PSQ) at a dose of 1 mg/kg in memory impairment and anxiety in an Alzheimer's disease (AD) model induced by amyloid β-peptide (Aβ) (fragment 25-35) in mice. The involvement of acetylcholinesterase (AChE) activity and lipid peroxidation in hippocampus and cerebral cortex was evaluated. Male Swiss mice were pretreated with 4-PSQ (1 mg/kg, intragastrically (i.g.), daily) for fourteen days. Thirty minutes after the first treatment with 4-PSQ, the animals received a single injection of Aβ (3 nmol/3 μl/per site, intracerebroventricular (i.c.v.)). Mice were submitted to the behavioral tasks (open-field, elevated plus maze, Barnes maze, object recognition and location, and step-down inhibitory avoidance tests) from the fifth day onwards. On the fifteenth day, blood was removed for analysis of biochemical markers (glucose, triglycerides, urea, aspartate (AST) and alanine (ALT) aminotrasferases), and cerebral cortex and hippocampus for determination of AChE activity and thiobarbituric acid reactive species (TBARS) levels. Aβ caused memory impairment, anxiogenic behavior, increased AChE activity in the cerebral structures and TBARS levels in the cerebral cortex. 4-PSQ was effective to protect against behavioral changes, AChE activity and TBARS levels. In conclusion, 4-PSQ protected against learning and memory impairment and anxiety in a mouse model of AD induced by Aβ, and anticholinesterase and antioxidant actions are involved in the pharmacological effect of the compound.

• Authors: Mikaela P Pinz, Angélica S Dos Reis, Ane G Vogt, Roberta Krüger, Diego Alves, Cristiano R Jesse, Silvane S Roman, Mauro P Soares, Ethel A Wilhelm, Cristiane Luchese
• Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie (Biomed Pharmacother) Vol. 105 Pg. 1006-1014 (Sep 2018) ISSN: 1950-6007 [Electronic] France
• PMID: 30021335 (Publication Type: Journal Article)
• Copyright: Copyright © 2018 Elsevier Masson SAS. All rights reserved.

Chemical References

• 7-chloro-4-phenylsulfonyl quinoline
• Amyloid beta-Peptides
• Peptide Fragments
• Quinolines
• amyloid beta-protein (25-35)

Topics

• Alzheimer Disease (chemically induced, drug therapy, metabolism)
• Amyloid beta-Peptides (toxicity)
• Animals
• Anxiety (chemically induced, metabolism, prevention & control)
• Cognitive Dysfunction (chemically induced, metabolism, prevention & control)
• Disease Models, Animal
• Locomotion (drug effects, physiology)
• Male
• Maze Learning (drug effects, physiology)
• Mice
• Peptide Fragments (toxicity)
• Quinolines (pharmacology, therapeutic use)
• Random Allocation